Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease-3

Copyright information:Taken from "Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease"BMC Neuroscience 2006;7():65-65.Published online 2 Oct 2006PMCID:PMC1609172. Figure 1 (see legend) at the indicated concentration. The reaction was carried out 4 times in duplicate for 24 hours and a representative blot from the four independent experiments is shown. 0 hour, reaction mixture stopped at time zero; 24 hours, control reaction lacking oligonucleotides. (Inset), The Flow-through from filter binding reaction containing HDG 20 (20 μM or 40 μM) was placed on blotting paper, dried and processed as described in the legend to Figure 1.